Application of the Web-based Acceptance and Commitment Therapy for Depression
ACTION
The Efficacy and Treatment Mechanisms of the Web-based Acceptance and Commitment Therapy for Patients with Major Depressive Disorder
1 other identifier
interventional
60
1 country
1
Brief Summary
PROSPECTIVE INTERVENTION STUDY; EFFICACY OF WEB-BASED ACCEPTANCE AND COMMITMENT THERAPY
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable major-depressive-disorder
Started Dec 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 19, 2022
CompletedFirst Submitted
Initial submission to the registry
February 18, 2024
CompletedFirst Posted
Study publicly available on registry
March 5, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2025
CompletedOctober 16, 2024
February 1, 2024
2.2 years
February 18, 2024
October 13, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Acceptance and Action Questionnaire-II
Psychological flexibility
6 weeks
Hamilton Rating Scale for Depression
Interviewer-rated depression scale
6 weeks
Secondary Outcomes (7)
Cognitive Fusion Questionnaire
6 weeks
Functional Connectivity
6 weeks
Valuing
6 weeks
Beck Depression Inventory
6 weeks
Beck Anxiety Inventory
6 weeks
- +2 more secondary outcomes
Study Arms (2)
ACT
EXPERIMENTALWeb-based ACT with treatment as usual
Controls
ACTIVE COMPARATORWaitlist being on the treatment as usual
Interventions
Eligibility Criteria
You may qualify if:
- Patients who diagnosed major depressive disorder
You may not qualify if:
- Patients who have serious medical problems, metal implants in their bodies, severe brain injury or brain disease
- Women who were pregnant or nursing
- Patients at high risk for suicide
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kyoung-Sae Na
Incheon, Please Incheon, 21565, South Korea
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
February 18, 2024
First Posted
March 5, 2024
Study Start
December 19, 2022
Primary Completion
February 28, 2025
Study Completion
February 28, 2025
Last Updated
October 16, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share